SCHEMBL1697231

SCHEMBL1697231

CC(CNS(C)(=O)=O)NCc1ccc(OCc2ccccc2F)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.61
SCN3A Q9NY46 1/20 0.50
BCHE P06276 1/20 0.48
MAOB P27338 7/20 0.48
PARP15 Q460N3 1/20 0.43
PARP14 Q460N5 1/20 0.43
PARP10 Q53GL7 1/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LPAR1 Q92633 1/20 0.40
LPAR5 Q9H1C0 1/20 0.40
MAOA P21397 1/20 0.40
PTPN1 P18031 1/20 0.40
GRIA4 P48058 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1697251 1.00 SCN9A (0.61) SCN9ASCN3ABCHEMAOBPARP15
SCHEMBL1697243 1.00 SCN9A (0.61) SCN9ASCN3ABCHEMAOBPARP15
SCHEMBL8638250 0.91 SCN9A (0.50) SCN9ASCN3ABCHENPC1RAB9A
SCHEMBL2939300 0.83 MCL1 (0.44) SCN9ARAB9ALMNAKMT2AKDM4E
SCHEMBL2934213 0.83 MCL1 (0.44) SCN9ARAB9ALMNAKMT2AKDM4E
SCHEMBL2933337 0.83 MCL1 (0.44) SCN9ARAB9ALMNAKMT2AKDM4E
SCHEMBL1672184 0.81 MAOB (0.62) SCN9ABCHEMAOBMAOA
SCHEMBL1665718 0.81 MAOB (0.62) SCN9ABCHEMAOBMAOA
SCHEMBL2940856 0.81 MAOB (0.62) SCN9ABCHEMAOBMAOA
Water SCHEMBL1672445 0.81 MAOB (0.61) SCN9ABCHEMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE40259-E1 side effects reduction; compounds active on the central nervous system; chronic and neuropathic pain, anti-epileptic, anti-Parkinson, neuroprotective, antidepressant, antispastic and hypnotic agents; 2-[4-(3-fluorobenzyloxy)benzylamino]-2-methylpropanamide NEWRON PHARMACEUTICALS, S.P.A. (IT) 2008-04-22 US claimed
EP-2563355-A1 PROCESS FOR THE PRODUCTION OF RALFINAMIDE METHANESULFONATE SALTS OR THEIR R-ENANTIOMERS Newron Pharmaceuticals S.p.A. (IT) 2013-03-06 EP disclosed
WO-2011134763-A1 PROCESS FOR THE PRODUCTION OF RALFINAMIDE METHANESULFONATE SALTS OR THEIR R-ENANTIOMERS NEWRON PHARMACEUTICALS S.P.A. (IT) 2011-11-03 WO disclosed